MOMENTA PHARMACEUTICALS INC 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Aug 14, 2015
Insider Transaction Report
Form 4
Franken Michael
President, Biosimilars Busines
Transactions
- Sale
Common Stock
2015-08-10$22.36/sh−20,000$447,200→ 39,001 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-08-10+20,000→ 50,000 totalExercise: $17.23From: 2014-12-10Exp: 2023-12-10→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2015-08-10$17.23/sh+20,000$344,600→ 59,001 total